JPWO2020219582A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020219582A5 JPWO2020219582A5 JP2021562097A JP2021562097A JPWO2020219582A5 JP WO2020219582 A5 JPWO2020219582 A5 JP WO2020219582A5 JP 2021562097 A JP2021562097 A JP 2021562097A JP 2021562097 A JP2021562097 A JP 2021562097A JP WO2020219582 A5 JPWO2020219582 A5 JP WO2020219582A5
- Authority
- JP
- Japan
- Prior art keywords
- culture medium
- cell culture
- cell
- acid
- aflibercept
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024205936A JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837263P | 2019-04-23 | 2019-04-23 | |
| US62/837,263 | 2019-04-23 | ||
| PCT/US2020/029370 WO2020219582A1 (en) | 2019-04-23 | 2020-04-22 | Cell culture medium for eukaryotic cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024205936A Division JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529485A JP2022529485A (ja) | 2022-06-22 |
| JP2022529485A5 JP2022529485A5 (https=) | 2023-04-21 |
| JPWO2020219582A5 true JPWO2020219582A5 (https=) | 2023-04-21 |
Family
ID=70681881
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562097A Pending JP2022529485A (ja) | 2019-04-23 | 2020-04-22 | 真核細胞用の細胞培地 |
| JP2024205936A Pending JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024205936A Pending JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US10961500B1 (https=) |
| EP (1) | EP3959234A1 (https=) |
| JP (2) | JP2022529485A (https=) |
| KR (1) | KR20220003563A (https=) |
| CN (1) | CN113710696A (https=) |
| AU (1) | AU2020262117B2 (https=) |
| BR (1) | BR112021020501A2 (https=) |
| CA (1) | CA3136827A1 (https=) |
| EA (1) | EA202192893A1 (https=) |
| IL (1) | IL287387A (https=) |
| MX (1) | MX2021012649A (https=) |
| MY (1) | MY198223A (https=) |
| SG (1) | SG11202111252QA (https=) |
| WO (1) | WO2020219582A1 (https=) |
| ZA (1) | ZA202107808B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10961500B1 (en) * | 2019-04-23 | 2021-03-30 | Regeneron Pharmaceuticals, Inc. | Cell culture medium for eukaryotic cells |
| WO2023278525A1 (en) * | 2021-06-29 | 2023-01-05 | Biomarin Pharmaceutical Inc. | Cell culture feed for recombinant adeno-associated virus production in mammalian cells |
| CN118240749B (zh) * | 2024-05-28 | 2024-08-06 | 烟台赛普生物技术有限公司 | 一种灌流培养基及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1312030C (en) * | 1987-11-18 | 1992-12-29 | Brian Maiorella | Method to increase antibody titer |
| EP1482031B1 (en) * | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| US7087411B2 (en) * | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US20030096414A1 (en) * | 2001-03-27 | 2003-05-22 | Invitrogen Corporation | Culture medium for cell growth and transfection |
| SG106672A1 (en) | 2002-03-08 | 2004-10-29 | Asml Netherlands Bv | Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method |
| ATE541919T1 (de) * | 2005-02-11 | 2012-02-15 | Novo Nordisk Healthcare Ag | Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält |
| WO2008154014A2 (en) * | 2007-06-11 | 2008-12-18 | Amgen Inc. | A method for culturing mammalian cells to improve recombinant protein production |
| BRPI0919034A8 (pt) * | 2008-09-26 | 2016-02-10 | Schering Corp | Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vaso |
| CN104059955A (zh) | 2009-08-11 | 2014-09-24 | 弗·哈夫曼-拉罗切有限公司 | 在无谷氨酰胺的细胞培养基中的蛋白质生产 |
| CA2805557A1 (en) * | 2010-07-08 | 2012-01-12 | Baxter International Inc. | Method of producing recombinant high molecular weight vwf in cell culture |
| US9677105B2 (en) * | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| AR095196A1 (es) * | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| TW202440904A (zh) | 2015-08-04 | 2024-10-16 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法（二） |
| KR102659791B1 (ko) * | 2017-07-06 | 2024-04-23 | 리제너론 파마슈티칼스 인코포레이티드 | 당단백질을 만들기 위한 세포 배양 과정 |
| US10961500B1 (en) * | 2019-04-23 | 2021-03-30 | Regeneron Pharmaceuticals, Inc. | Cell culture medium for eukaryotic cells |
-
2020
- 2020-01-27 US US16/752,874 patent/US10961500B1/en active Active
- 2020-04-22 MY MYPI2021006125A patent/MY198223A/en unknown
- 2020-04-22 KR KR1020217037669A patent/KR20220003563A/ko active Pending
- 2020-04-22 CN CN202080030558.8A patent/CN113710696A/zh active Pending
- 2020-04-22 BR BR112021020501A patent/BR112021020501A2/pt unknown
- 2020-04-22 MX MX2021012649A patent/MX2021012649A/es unknown
- 2020-04-22 WO PCT/US2020/029370 patent/WO2020219582A1/en not_active Ceased
- 2020-04-22 EP EP20725601.7A patent/EP3959234A1/en active Pending
- 2020-04-22 JP JP2021562097A patent/JP2022529485A/ja active Pending
- 2020-04-22 EA EA202192893A patent/EA202192893A1/ru unknown
- 2020-04-22 CA CA3136827A patent/CA3136827A1/en active Pending
- 2020-04-22 SG SG11202111252QA patent/SG11202111252QA/en unknown
- 2020-04-22 AU AU2020262117A patent/AU2020262117B2/en active Active
-
2021
- 2021-03-24 US US17/211,596 patent/US11286460B2/en active Active
- 2021-10-14 ZA ZA2021/07808A patent/ZA202107808B/en unknown
- 2021-10-19 IL IL287387A patent/IL287387A/en unknown
-
2022
- 2022-02-22 US US17/677,163 patent/US11555176B2/en active Active
- 2022-12-13 US US18/080,373 patent/US11821001B2/en active Active
-
2023
- 2023-11-20 US US18/514,880 patent/US20240084248A1/en active Pending
-
2024
- 2024-11-27 JP JP2024205936A patent/JP2025028979A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7034991B2 (ja) | 改良型細胞培養培地 | |
| JP6982578B2 (ja) | 細胞培養培地 | |
| KR101828624B1 (ko) | 개선된 세포 배양 방법 | |
| JP5808742B2 (ja) | 連続細胞培養で対象となるポリペプチドまたはウイルスを生成する方法 | |
| RU2592680C2 (ru) | Способ снижения накопления лактата при культивировании и способ получения антитела | |
| AU2014288811B2 (en) | Improved process for production of monoclonal antibodies | |
| JP6948942B2 (ja) | タンパク質産物の等電性プロファイルをシフトさせる方法およびその使用 | |
| JP2019154450A (ja) | 培養培地の最適化により組換えタンパク質のガラクトシル化を調節する方法 | |
| WO2011134921A1 (en) | Improved cell culture medium | |
| JP6108170B2 (ja) | 細胞培養用培地 | |
| JPWO2020219582A5 (https=) | ||
| KR101318498B1 (ko) | 재조합 단백질의 생산성 향상을 위한 배양용 배지 첨가용 조성물 | |
| WO2020035050A1 (zh) | 用于调节哺乳动物细胞乳酸代谢的培养基及其应用 | |
| US10526631B1 (en) | Method of reducing serine for asparagine misincorporation | |
| JP2749011B2 (ja) | 無血清培地で増殖継代可能な細胞およびその取得方法 | |
| JP2009514532A (ja) | 哺乳動物細胞を適応させるための方法 | |
| US20170233695A1 (en) | Cell Culture Media Composition and Methods of Producing Thereof | |
| US11254964B1 (en) | Cell culture methods for increased cell viability | |
| TWI920111B (zh) | 細胞培養基 | |
| JP2019526265A (ja) | 組換えタンパク質の生産プロファイルを改変するための方法 |